US Stock MarketDetailed Quotes

VINC Vincerx Pharma

Watchlist
  • 0.700
  • -0.020-2.72%
Close May 22 16:00 ET
  • 0.700
  • 0.0000.00%
Pre 05:05 ET
20.67MMarket Cap-393P/E (TTM)

Vincerx Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-51.47%7.48M
-38.00%42.61M
-57.57%5.53M
-33.83%10.32M
-36.85%11.66M
-28.76%15.41M
9.68%68.72M
-26.36%13.04M
-13.05%15.59M
6.16%18.46M
Selling and administrative expenses
-35.02%2.92M
-27.79%13.64M
-54.29%1.82M
-22.28%3.52M
-19.80%3.79M
-20.49%4.5M
-16.35%18.89M
-25.83%3.98M
-20.89%4.53M
-29.47%4.72M
-General and administrative expense
-35.02%2.92M
-27.79%13.64M
-54.29%1.82M
-22.28%3.52M
-19.80%3.79M
-20.49%4.5M
-16.35%18.89M
-25.83%3.98M
-20.89%4.53M
-29.47%4.72M
Research and development costs
-58.24%4.56M
-41.86%28.97M
-59.01%3.71M
-38.55%6.8M
-42.71%7.87M
-31.68%10.91M
24.34%49.84M
-26.58%9.06M
-9.38%11.07M
28.45%13.74M
Operating profit
51.47%-7.48M
38.00%-42.61M
57.57%-5.53M
33.83%-10.32M
36.85%-11.66M
28.76%-15.41M
-9.68%-68.72M
26.36%-13.04M
13.05%-15.59M
-6.16%-18.46M
Net non-operating interest income expense
-78.76%99K
88.40%1.25M
-56.96%198K
27.45%260K
327K
466K
664K
460K
204K
0
Non-operating interest income
-78.76%99K
88.40%1.25M
-56.96%198K
27.45%260K
--327K
--466K
--664K
--460K
--204K
--0
Other net income (expense)
-1,829.45%-5.05M
-76.33%1.2M
-70.83%385K
122.92%342K
323.26%182K
-94.39%292K
-78.27%5.07M
-88.25%1.32M
77.37%-1.49M
-99.72%43K
Gain on sale of security
-29,011.11%-5.2M
-100.75%-47K
-90.32%-59K
241.77%112K
-109.82%-118K
-99.65%18K
-73.02%6.3M
-100.28%-31K
98.80%-79K
-92.17%1.2M
Special income (charges)
----
--0
--0
--0
--0
----
---2.47M
--0
---1.31M
---1.16M
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
--0
----
--2.47M
--0
--1.31M
--1.16M
Other non- operating income (expenses)
-43.80%154K
0.65%1.25M
-67.14%444K
323.30%230K
--300K
3,525.00%274K
15,600.00%1.24M
6,533.33%1.35M
-892.31%-103K
----
Income before tax
15.16%-12.43M
36.24%-40.16M
56.04%-4.95M
42.44%-9.72M
39.47%-11.15M
10.80%-14.65M
-60.24%-62.98M
-73.98%-11.26M
31.17%-16.88M
-805.65%-18.42M
Income tax
Net income
15.16%-12.43M
36.24%-40.16M
56.04%-4.95M
42.44%-9.72M
39.47%-11.15M
10.80%-14.65M
-60.24%-62.98M
-73.98%-11.26M
31.17%-16.88M
-805.65%-18.42M
Net income continuous Operations
15.16%-12.43M
36.24%-40.16M
56.04%-4.95M
42.44%-9.72M
39.47%-11.15M
10.80%-14.65M
-60.24%-62.98M
-73.98%-11.26M
31.17%-16.88M
-805.65%-18.42M
Minority interest income
Net income attributable to the parent company
15.16%-12.43M
36.24%-40.16M
56.04%-4.95M
42.44%-9.72M
39.47%-11.15M
10.80%-14.65M
-60.24%-62.98M
-73.98%-11.26M
31.17%-16.88M
-805.65%-18.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.16%-12.43M
36.24%-40.16M
56.04%-4.95M
42.44%-9.72M
39.47%-11.15M
10.80%-14.65M
-60.24%-62.98M
-73.98%-11.26M
31.17%-16.88M
-805.65%-18.42M
Basic earnings per share
15.94%-0.58
37.00%-1.89
64.62%-0.23
42.50%-0.46
40.91%-0.52
12.66%-0.69
-31.00%-3
-109.68%-0.65
42.45%-0.8
-633.33%-0.88
Diluted earnings per share
15.94%-0.58
37.00%-1.89
64.62%-0.23
42.50%-0.46
40.91%-0.52
12.66%-0.69
-31.00%-3
-109.68%-0.65
42.45%-0.8
-633.33%-0.88
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -51.47%7.48M-38.00%42.61M-57.57%5.53M-33.83%10.32M-36.85%11.66M-28.76%15.41M9.68%68.72M-26.36%13.04M-13.05%15.59M6.16%18.46M
Selling and administrative expenses -35.02%2.92M-27.79%13.64M-54.29%1.82M-22.28%3.52M-19.80%3.79M-20.49%4.5M-16.35%18.89M-25.83%3.98M-20.89%4.53M-29.47%4.72M
-General and administrative expense -35.02%2.92M-27.79%13.64M-54.29%1.82M-22.28%3.52M-19.80%3.79M-20.49%4.5M-16.35%18.89M-25.83%3.98M-20.89%4.53M-29.47%4.72M
Research and development costs -58.24%4.56M-41.86%28.97M-59.01%3.71M-38.55%6.8M-42.71%7.87M-31.68%10.91M24.34%49.84M-26.58%9.06M-9.38%11.07M28.45%13.74M
Operating profit 51.47%-7.48M38.00%-42.61M57.57%-5.53M33.83%-10.32M36.85%-11.66M28.76%-15.41M-9.68%-68.72M26.36%-13.04M13.05%-15.59M-6.16%-18.46M
Net non-operating interest income expense -78.76%99K88.40%1.25M-56.96%198K27.45%260K327K466K664K460K204K0
Non-operating interest income -78.76%99K88.40%1.25M-56.96%198K27.45%260K--327K--466K--664K--460K--204K--0
Other net income (expense) -1,829.45%-5.05M-76.33%1.2M-70.83%385K122.92%342K323.26%182K-94.39%292K-78.27%5.07M-88.25%1.32M77.37%-1.49M-99.72%43K
Gain on sale of security -29,011.11%-5.2M-100.75%-47K-90.32%-59K241.77%112K-109.82%-118K-99.65%18K-73.02%6.3M-100.28%-31K98.80%-79K-92.17%1.2M
Special income (charges) ------0--0--0--0-------2.47M--0---1.31M---1.16M
-Less：Restructuring and merger&acquisition ------0--0--0--0------2.47M--0--1.31M--1.16M
Other non- operating income (expenses) -43.80%154K0.65%1.25M-67.14%444K323.30%230K--300K3,525.00%274K15,600.00%1.24M6,533.33%1.35M-892.31%-103K----
Income before tax 15.16%-12.43M36.24%-40.16M56.04%-4.95M42.44%-9.72M39.47%-11.15M10.80%-14.65M-60.24%-62.98M-73.98%-11.26M31.17%-16.88M-805.65%-18.42M
Income tax
Net income 15.16%-12.43M36.24%-40.16M56.04%-4.95M42.44%-9.72M39.47%-11.15M10.80%-14.65M-60.24%-62.98M-73.98%-11.26M31.17%-16.88M-805.65%-18.42M
Net income continuous Operations 15.16%-12.43M36.24%-40.16M56.04%-4.95M42.44%-9.72M39.47%-11.15M10.80%-14.65M-60.24%-62.98M-73.98%-11.26M31.17%-16.88M-805.65%-18.42M
Minority interest income
Net income attributable to the parent company 15.16%-12.43M36.24%-40.16M56.04%-4.95M42.44%-9.72M39.47%-11.15M10.80%-14.65M-60.24%-62.98M-73.98%-11.26M31.17%-16.88M-805.65%-18.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.16%-12.43M36.24%-40.16M56.04%-4.95M42.44%-9.72M39.47%-11.15M10.80%-14.65M-60.24%-62.98M-73.98%-11.26M31.17%-16.88M-805.65%-18.42M
Basic earnings per share 15.94%-0.5837.00%-1.8964.62%-0.2342.50%-0.4640.91%-0.5212.66%-0.69-31.00%-3-109.68%-0.6542.45%-0.8-633.33%-0.88
Diluted earnings per share 15.94%-0.5837.00%-1.8964.62%-0.2342.50%-0.4640.91%-0.5212.66%-0.69-31.00%-3-109.68%-0.6542.45%-0.8-633.33%-0.88
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg